Ensign Peak Advisors’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-8,080
| Closed | -$42K | – | 2345 |
|
2022
Q2 | $42K | Hold |
8,080
| – | – | ﹤0.01% | 2083 |
|
2022
Q1 | $56K | Hold |
8,080
| – | – | ﹤0.01% | 2114 |
|
2021
Q4 | $101K | Buy |
+8,080
| New | +$101K | ﹤0.01% | 2058 |
|
2021
Q2 | – | Sell |
-17,498
| Closed | -$758K | – | 1847 |
|
2021
Q1 | $758K | Buy |
+17,498
| New | +$758K | ﹤0.01% | 1504 |
|